Funding opportunity

Konsul Th C Berghs foundation, a Swedish funding body, provides financial support for allergy research and each year donates 1 miljon SEK to Swedish scientists working within this field. Applications are welcome between 28th October 2021 and 16th December 2021. For more information click here

Forthcoming asthma and allergy conferences

PAAM DIGITAL 2021 The EAACI Pediatric Allergy and Asthma Meeting will take place digitally on 12–13 November 2021

EAACI WINTER SCHOOL 27-30 Jan 2022 on basic immunology research in allergy and clinical immunology. Hybrid meeting, Semmering, Austria

Collegium Internationale Allergologicum (CIA) symposium, 22-26 May, 2022, entitled Shifting Paradigms in Allergy and Immune Disease: Diagnosis & Management will be held in Montréal, Quebec

EAACI 1-3 July 2022, Hybrid meeting, Prague, Czech Republic

American Thoracic Society 13-18 May 2022, San Francisco, CA, USA. Abstract deadline 3 November 2021

European Respiratory Society 4-6 September 2022, Barcelona, Spain

Recent publications by CfA researchers

Just accepted in the European Respiratory Journal:

Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED Study. Reinke S, Naz S, Chaleckis R, Ayala H, Kolmert J, Kermani N, Tiotiu A, Broadhurst D, Lundqvist A, Olsson H, Wheelock Å, Strom M, Gomez C, Ericsson M, Sousa A, Riley J, Bates S, Schofield J, Loza M, Baribaud F, Bakke P, Massimo C; Chanez P, Fowler S, Geiser T, Howarth P, Horváth I, Krug N, Montuschi P, Behndig A, Singer F, Musial J, Shaw D, Dahlén B, Hu S, Lasky-Su J, Sterk P, Chung KF, Djukanovic R, Dahlén SE, Adcock I, Wheelock C.

Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation. Sparreman Mikus M, Kolmert J, Andersson LI, Östling J, Knowles RG, Gómez C, Ericsson M, Thörngren JO, Emami Khoonsari P, Dahlén B, Kupczyk M, De Meulder B, Auffray C, Bakke PS, Beghe B, Bel EH, Caruso M, Chanez P, Chawes B, Fowler SJ, Gaga M, Geiser T, Gjomarkaj M, Horváth I, Howarth PH, Johnston SJ, Joos G, Krug N, Montuschi P, Musial J, Niżankowska-Mogilnicka E, Olsson HK, Papi A, Rabe KF, Sandström T, Shaw DE, Siafakas NM, Uhlén M, Riley JH, Bates S, Middelveld RJM, Wheelock CE, Chung KF, Adcock IM, Sterk PJ, Djukanovic R, Nilsson P, Dahlén SE, James A, on behalf of the U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Disease outcome) Study Group and the BIOAIR (Longitudinal Assessment of Clinical Course and Biomarkers in Severe Chronic Airway Disease) Consortium.

Monensin induces selective mast cell apoptosis through a secretory granule-mediated pathway. Maccarana M, Liu J, Lampinen M, Rollman O, Adner M, Pejler G, Paivandy A.Allergy. 2021 Oct 27. doi: 10.1111/all.15157.

Filaggrin mutations in relation to skin barrier and atopic dermatitis in early infancy. Hoyer A, Rehbinder EM, Färdig M, Asad S, Lødrup Carlsen KC, Endre KMA, Granum B, Haugen G, Hedlin G, Monceyron Jonassen C, Katayama S, Konradsen JR, Landrø L, LeBlanc M, Mägi Olsson CA, Rudi K, Skjerven HO, Staff AC, Vettukattil R, Bradley M, Nordlund B, Söderhäll C. Br J Dermatol. 2021 Oct 26. doi: 10.1111/bjd.20831.

The Role of PPAR-γ in Allergic Disease. Stark JM, Coquet JM, Tibbitt CA. Curr Allergy Asthma Rep. 2021 Oct 25;21(11):45.

The majority of children sensitized before school-age develop allergic disease before adulthood: a longitudinal population-based study. Bunne J, Hedman L, Perzanowski M, Bjerg A, Winberg A, Andersson M, Lundbäck B, Platts-Mills T, Rönmark E. J Allergy Clin Immunol Pract. 2021 Oct 22:S2213-2198(21)01142-9.

ALPHA-GAL SENSITIZATION AMONG YOUNG ADULTS IS ASSOCIATED WITH MALE SEX AND POLYSENSITIZATION. Westman M, Asarnoj A, Ballardini N, Andersson N, Kiewiet MBG, Borres MP, Apostolovic D, Kull I, Bergström A, Melén E, van Hage M. J Allergy Clin Immunol Pract. 2021 Oct 20:S2213-2198(21)01137-5.

Parental socioeconomic status and asthma in children - using a population-based cohort and family design. Caffrey Osvald E, Gong T, Lundholm C, Larsson H, Katie Brew B, Almqvist C. Clin Exp Allergy. 2021 Oct 22.

3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD. Porsbjerg C, Maitland-van der Zee AH, Brusselle G, Canonica GW, Agusti A, Faner R, Vogelmeier CF, Nawijn M, van den Berge M, Rusconi F, Pilette C, Ramiconi V, Coleman C, Chaudhuri R, Chung KF, Wedzicha J, Saglani S, Van der Schee MP, Heaney L, Bourdin A, Roberts G, Djukanovic R, Kuna P, Kupczyk M, Axmann J, Staudinger H, Clarke GW, Dahlen SE, Brightling C. Eur Respir J. 2021 Oct 21;58(4):2102168.

Uncontrolled asthma from childhood to young adulthood associates with airflow obstruction. Mogensen I, Hallberg J, Ekström S, Bergström A, Melén E, Kull I. ERJ Open Res. 2021 Oct 18;7(4):00179-2021.

Transcriptome changes during peanut oral immunotherapy and omalizumab treatment. Björkander S, Merid SK, Brodin D, Brandström J, Fagerström-Billai F, van der Heiden M, Konradsen JR, Kabesch M, van Drunen CM, Golebski K, Maitland-van der Zee AH, Potočnik U, Vijverberg SJH, Nopp A, Nilsson C, Melén E. Pediatr Allergy Immunol. 2021 Oct 20. doi: 10.1111/pai.13682.

Allergy-related diseases in childhood and risk for abdominal pain-related functional gastrointestinal disorders at 16 years-a birth cohort study. Sjölund J, Kull I, Bergström A, Järås J, Ludvigsson JF, Törnblom H, Simrén M, Olén O.Sjölund J, et al. BMC Med. 2021 Sep 16;19(1):214.

Preterm birth reduces the risk of IgE sensitization up to early adulthood: A population-based birth cohort study.Mitselou N, Andersson N, Bergström A, Kull I, Georgelis A, van Hage M, Hedman AM, Almqvist C, Ludvigsson JF, Melén E.Mitselou N, et al. Allergy. 2021 Sep 6. doi: 10.1111/all.15077.